動物用医薬品原薬市場：事業別、適応症別、合成別、タイプ別、エンドユーザー別-2025-2030年世界予測

動物用医薬品原薬市場は、2023年に174億1,000万米ドルと評価され、2024年には188億2,000万米ドルに達すると予測され、CAGR 8.23％で成長し、2030年には302億8,000万米ドルに達すると予測されています。

動物用医薬品原薬（API）市場には、動物の健康と生産性を向上させる動物用医薬品の製造に使用される生物学的活性物質の製剤が含まれます。APIの必要性は、人獣共通感染症を管理し、家畜の健康を改善して質の高い食糧生産を確保し、コンパニオンアニマル・ケアを強化する必要性の高まりから生じています。用途は抗生物質、抗寄生虫薬、抗炎症薬、ワクチン、栄養補助食品など多岐にわたり、動物病院、診療所、農場など様々な最終用途に対応しています。この市場に影響を与える主な成長要因としては、ペット飼育の増加、動物疾病の発生率の上昇、食の安全性と持続可能な農業慣行の重視の高まりなどが挙げられます。有機食肉製品に対する需要の急増も市場の成長を促進し、天然で環境に優しいAPIの開発に潜在的な機会を生み出しています。市場の主なプレーヤーは、バイオテクノロジーに基づくAPI製剤の革新とドラッグデリバリーシステムの進歩により、この動向を活用することができます。

市場の成長に影響を与える課題には、厳しい規制の枠組み、原薬開発の高コスト、抗生物質耐性の出現などがあります。さらに、サプライチェーンの混乱や原料価格の変動も大きな障害となっています。とはいえ、研究開発への戦略的投資は、より効率的な生産プロセスや新規の治療ソリューションを可能にすることで、こうした課題を軽減することができます。技術革新の機が熟している分野には、獣医学的用途に合わせた精密医療や、原薬の有効性と入手しやすさの飛躍的向上につながる可能性のある、創薬におけるAIの活用が含まれます。

市場はダイナミックな性質を示し、遠隔医療や健康監視装置など、動物医療にデジタルヘルスツールを統合する傾向が強まっています。こうした機会を効果的に捉えるには、利害関係者は戦略的パートナーシップを形成し、技術の進歩を活用し、進化する消費者の嗜好や規制基準に沿った持続可能な慣行を維持する必要があります。強固なサプライチェーンを確立し、市場に特化した療法に投資することで、市場のポジショニングと長期的な成長をさらに高めることができます。

市場力学：急速に進化する動物用医薬品原薬市場における主要市場インサイトの解明

動物用医薬品原薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のペット飼育率の上昇
  • 動物ヘルスケアに対する人々の認識と支出の増加
  • 動物ヘルスケアNGOの著しい増加
• 市場抑制要因
  • 動物用医薬品に関連するいくつかのリスク要因
• 市場機会
  • 動物の健康に対する人々の意識の高まり
  • 動物の生産性の向上
• 市場の課題
  • 限られた認識と原料コストの変動

ポーターの5つの力：動物用医薬品原薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用医薬品原薬市場における外部からの影響の把握

外部マクロ環境要因は、動物用医薬品原薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用医薬品原薬市場における競合情勢の把握

動物用医薬品原薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用医薬品原薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用医薬品原薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用医薬品原薬市場における成功への道筋を描く

動物用医薬品原薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でペットの飼育が増加
    • 動物のヘルスケアに関する人々の意識と支出の増加
    • 動物ヘルスケアNGOの数が著しく増加
  • 抑制要因
    • 動物用医薬品APIに関連するいくつかのリスク要因
  • 機会
    • 動物の健康に関する人々の意識の高まり
    • 動物の生産性の向上
  • 課題
    • 原材料費の認識不足と変動
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用医薬品原薬市場：事業別

• キャプティブ有効医薬品成分
• 商人有効医薬品成分

第7章 動物用医薬品原薬市場適応症別

• 抗感染薬
• 駆虫薬
• 非ステロイド性抗炎症薬および麻酔薬

第8章 動物用医薬品原薬市場合成別

• バイオテクノロジー
• 合成

第9章 動物用医薬品原薬市場：タイプ別

• ブランド
• ジェネリック

第10章 動物用医薬品原薬市場：エンドユーザー別

• ペットケア病院
• 小売・専門薬局

第11章 南北アメリカの動物用医薬品原薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の動物用医薬品原薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの動物用医薬品原薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Changzhou Yabang-Qh Pharmachem Co., Ltd.
• Eli Lilly & Co.
• Excel Industries Limited
• Glenmark Pharmaceutical Ltd.
• Heska Corporation
• HIKAL Ltd.
• Indukern, S.A.
• Lonza Group AG
• NGL Fine Chem Ltd.
• Ofichem BV
• Orion Corporation
• Sequent Scientific Ltd.
• Suanfarma, SA
• Zhejiang Hisun Pharmaceutical Co. Ltd
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET RESEARCH PROCESS
• FIGURE 2. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET DYNAMICS
• TABLE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY CAPTIVE ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MERCHANT ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS & ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BIOTECH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PET CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY RETAIL & SPECIALTY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 40. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 67. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 73. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 127. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 158. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 178. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 183. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 184. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY BUSINESS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SYNTHESIS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 233. ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Animal Health Active Pharmaceutical Ingredients Market was valued at USD 17.41 billion in 2023, expected to reach USD 18.82 billion in 2024, and is projected to grow at a CAGR of 8.23%, to USD 30.28 billion by 2030.

The Animal Health Active Pharmaceutical Ingredients (APIs) market encompasses the formulation of biologically active substances used in the manufacture of veterinary medicines that improve animal health and productivity. The necessity for APIs arises from the growing need to manage zoonotic diseases, improve livestock health to ensure quality food production, and enhance companion animal care. Applications span across antibiotics, anti-parasitic and anti-inflammatory drugs, vaccines, and nutritional supplements, serving various end-use segments such as veterinary hospitals, clinics, and farms. Key growth factors influencing this market include increasing pet ownership, rising incidences of animal diseases, and a growing emphasis on food safety and sustainable farming practices. The surge in demand for organic meat products also propels market growth, creating potential opportunities in the development of natural and eco-friendly APIs. Market players can capitalize on this trend by innovating in biotechnology-based API formulations and advancing in drug delivery systems.

Challenges affecting market growth include stringent regulatory frameworks, high costs of API development, and the advent of antibiotic resistance. Moreover, supply chain disruptions and fluctuating raw material prices pose significant hurdles. Nevertheless, strategic investments in R&D can mitigate these challenges by enabling more efficient production processes and novel therapeutic solutions. Areas ripe for innovation include precision medicine tailored for veterinary applications and the utilization of AI in drug discovery, which can lead to breakthroughs in API effectiveness and accessibility.

The market exhibits a dynamic nature with a growing inclination towards integrating digital health tools in animal care, such as telemedicine and health monitoring devices, thereby opening new vistas for API applications. To effectively capture these opportunities, stakeholders need to form strategic partnerships, leverage technological advancements, and maintain sustainable practices that align with evolving consumer preferences and regulatory standards. Establishing robust supply chains and investing in market-specific therapies can further enhance market positioning and long-term growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Animal Health Active Pharmaceutical Ingredients Market

The Animal Health Active Pharmaceutical Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising adoption of pets across the globe
  • Increasing awareness and expenditure among people regarding the animal healthcare
  • Significant growth in the number of animal healthcare NGOs
• Market Restraints
  • Several risk factors associated with animal health APIs
• Market Opportunities
  • Growing awareness amongst people regarding animal health
  • Improvements in the animal productivity
• Market Challenges
  • Limited awareness and variations in raw material cost

Porter's Five Forces: A Strategic Tool for Navigating the Animal Health Active Pharmaceutical Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Animal Health Active Pharmaceutical Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Animal Health Active Pharmaceutical Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Animal Health Active Pharmaceutical Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Animal Health Active Pharmaceutical Ingredients Market

A detailed market share analysis in the Animal Health Active Pharmaceutical Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Animal Health Active Pharmaceutical Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Animal Health Active Pharmaceutical Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Animal Health Active Pharmaceutical Ingredients Market

A strategic analysis of the Animal Health Active Pharmaceutical Ingredients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Animal Health Active Pharmaceutical Ingredients Market, highlighting leading vendors and their innovative profiles. These include Changzhou Yabang-Qh Pharmachem Co., Ltd., Eli Lilly & Co., Excel Industries Limited, Glenmark Pharmaceutical Ltd., Heska Corporation, HIKAL Ltd., Indukern, S.A., Lonza Group AG, NGL Fine Chem Ltd., Ofichem BV, Orion Corporation, Sequent Scientific Ltd., Suanfarma, SA, Zhejiang Hisun Pharmaceutical Co. Ltd, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Animal Health Active Pharmaceutical Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Business, market is studied across Captive Active Pharmaceutical Ingredient and Merchant Active Pharmaceutical Ingredient.
• Based on Indication, market is studied across Anti-Infectives, Antiparasitics, and Non-Steroidal Anti-Inflammatory Drugs & Anesthetics.
• Based on Synthesis, market is studied across Biotech and Synthetic.
• Based on Type, market is studied across Branded and Generic.
• Based on End User, market is studied across Pet Care Hospitals and Retail & Specialty Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising adoption of pets across the globe
    • 5.1.1.2. Increasing awareness and expenditure among people regarding the animal healthcare
    • 5.1.1.3. Significant growth in the number of animal healthcare NGOs
  • 5.1.2. Restraints
    • 5.1.2.1. Several risk factors associated with animal health APIs
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing awareness amongst people regarding animal health
    • 5.1.3.2. Improvements in the animal productivity
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness and variations in raw material cost
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Animal Health Active Pharmaceutical Ingredients Market, by Business

• 6.1. Introduction
• 6.2. Captive Active Pharmaceutical Ingredient
• 6.3. Merchant Active Pharmaceutical Ingredient

7. Animal Health Active Pharmaceutical Ingredients Market, by Indication

• 7.1. Introduction
• 7.2. Anti-Infectives
• 7.3. Antiparasitics
• 7.4. Non-Steroidal Anti-Inflammatory Drugs & Anesthetics

8. Animal Health Active Pharmaceutical Ingredients Market, by Synthesis

• 8.1. Introduction
• 8.2. Biotech
• 8.3. Synthetic

9. Animal Health Active Pharmaceutical Ingredients Market, by Type

• 9.1. Introduction
• 9.2. Branded
• 9.3. Generic

10. Animal Health Active Pharmaceutical Ingredients Market, by End User

• 10.1. Introduction
• 10.2. Pet Care Hospitals
• 10.3. Retail & Specialty Pharmacies

11. Americas Animal Health Active Pharmaceutical Ingredients Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Animal Health Active Pharmaceutical Ingredients Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Animal Health Active Pharmaceutical Ingredients Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Changzhou Yabang-Qh Pharmachem Co., Ltd.
• 2. Eli Lilly & Co.
• 3. Excel Industries Limited
• 4. Glenmark Pharmaceutical Ltd.
• 5. Heska Corporation
• 6. HIKAL Ltd.
• 7. Indukern, S.A.
• 8. Lonza Group AG
• 9. NGL Fine Chem Ltd.
• 10. Ofichem BV
• 11. Orion Corporation
• 12. Sequent Scientific Ltd.
• 13. Suanfarma, SA
• 14. Zhejiang Hisun Pharmaceutical Co. Ltd
• 15. Zoetis Inc.